DE3686536D1 - OXYTOCIN AND ANTI-DAYS TO INTRODUCE BIRTH. - Google Patents

OXYTOCIN AND ANTI-DAYS TO INTRODUCE BIRTH.

Info

Publication number
DE3686536D1
DE3686536D1 DE8686730118T DE3686536T DE3686536D1 DE 3686536 D1 DE3686536 D1 DE 3686536D1 DE 8686730118 T DE8686730118 T DE 8686730118T DE 3686536 T DE3686536 T DE 3686536T DE 3686536 D1 DE3686536 D1 DE 3686536D1
Authority
DE
Germany
Prior art keywords
oxytocin
per
antigestagen
birth
pref
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686730118T
Other languages
German (de)
Inventor
Krsysztof Chwalisz
Sybille Beier
Walter Elger
Gunter Neef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE8686730118T priority Critical patent/DE3686536D1/en
Application granted granted Critical
Publication of DE3686536D1 publication Critical patent/DE3686536D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Abstract

Combination preparations for joint use in inducing birth or for the therapeutic termination of pregnancy contain oxytocin or an oxytocin analogue (Ox) and an antigestagen (AG) are claimed. Separate (pref. non-simultaneous) joint use of oxytocin or an oxytocin analogue and an antigestagen for inducing birth or for therapeutically terminating pregnancy is also claimed. Pref. prod. contain (A) 1-10 IO oxytocin per ml injection solution, 0.5-2 IU per ml infusion solution or 100-300 IU per buccal tablet and (B) 10-200 mg 11beta-(4-dimethylamino-phenyl) -17alpha-hydroxy -17beta-(3-hydroxypropyl)-13alpha-methyl-4,9(10) -gonadien-3-one or a biologically equivalent amt. of a different antigestagen per dosage unit.
DE8686730118T 1985-09-05 1986-07-25 OXYTOCIN AND ANTI-DAYS TO INTRODUCE BIRTH. Expired - Lifetime DE3686536D1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE8686730118T DE3686536D1 (en) 1985-09-05 1986-07-25 OXYTOCIN AND ANTI-DAYS TO INTRODUCE BIRTH.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853531903 DE3531903A1 (en) 1985-09-05 1985-09-05 OXYTOCIN AND ANTI-DAYS FOR THE INTRODUCTION OF BIRTH OR ON THE THERAPEUTIC STOP OF GRAVIDITY
DE8686730118T DE3686536D1 (en) 1985-09-05 1986-07-25 OXYTOCIN AND ANTI-DAYS TO INTRODUCE BIRTH.

Publications (1)

Publication Number Publication Date
DE3686536D1 true DE3686536D1 (en) 1992-10-01

Family

ID=6280317

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19853531903 Withdrawn DE3531903A1 (en) 1985-09-05 1985-09-05 OXYTOCIN AND ANTI-DAYS FOR THE INTRODUCTION OF BIRTH OR ON THE THERAPEUTIC STOP OF GRAVIDITY
DE8686730118T Expired - Lifetime DE3686536D1 (en) 1985-09-05 1986-07-25 OXYTOCIN AND ANTI-DAYS TO INTRODUCE BIRTH.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19853531903 Withdrawn DE3531903A1 (en) 1985-09-05 1985-09-05 OXYTOCIN AND ANTI-DAYS FOR THE INTRODUCTION OF BIRTH OR ON THE THERAPEUTIC STOP OF GRAVIDITY

Country Status (11)

Country Link
US (1) US4870067A (en)
EP (1) EP0214924B1 (en)
JP (1) JPH0764743B2 (en)
AT (1) ATE79765T1 (en)
AU (1) AU596988B2 (en)
CA (1) CA1281286C (en)
DE (2) DE3531903A1 (en)
DK (1) DK164480C (en)
GR (1) GR862253B (en)
IE (1) IE59191B1 (en)
ZA (1) ZA866770B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9124775D0 (en) * 1991-11-21 1992-01-15 Medical Res Council Cervical ripening
GB9406463D0 (en) * 1994-03-31 1994-05-25 Medical Res Council Cervical ripening

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005200A (en) * 1975-07-17 1977-01-25 Kanebo, Ltd. Method for improving the maturity of the parturient canal and the sensitivity to oxytocin
CS194980B1 (en) * 1976-07-16 1979-12-31 Joseph H Cort Agent for current induction,fertilization facilitating and milkability increasing at mammals,especially at utility cattle
US4160027A (en) * 1977-12-20 1979-07-03 Sterling Drug Inc. Steroid cyanoketones and intermediates
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
DE3413036A1 (en) * 1984-04-04 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen 13a-Alkylgonanes, the preparation thereof and pharmaceutical products containing these
DE3337450A1 (en) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen PROSTAGLANDINE AND ANTIGESTAGE FOR PREGNANCY ABORT
DE3347126A1 (en) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11SS-ARYL-ESTRADIENE, THEIR PRODUCTION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM
FR2573657B1 (en) * 1984-11-29 1989-05-12 Roussel Uclaf PRODUCT COMPRISING AN ANTIPROGESTOMIMETIC SUBSTANCE AND A UTEROTONIC SUBSTANCE
US4672226A (en) * 1985-03-08 1987-06-09 Westinghouse Electric Corp. Redundant resistance temperature detector power supply system

Also Published As

Publication number Publication date
DK164480C (en) 1992-11-23
JPS6256439A (en) 1987-03-12
IE862336L (en) 1987-03-05
JPH0764743B2 (en) 1995-07-12
GR862253B (en) 1986-12-31
IE59191B1 (en) 1994-01-26
DK164480B (en) 1992-07-06
EP0214924B1 (en) 1992-08-26
CA1281286C (en) 1991-03-12
ATE79765T1 (en) 1992-09-15
EP0214924A3 (en) 1989-05-24
DK383986A (en) 1987-03-06
EP0214924A2 (en) 1987-03-18
US4870067A (en) 1989-09-26
AU596988B2 (en) 1990-05-24
DE3531903A1 (en) 1987-03-12
ZA866770B (en) 1987-04-29
DK383986D0 (en) 1986-08-12
AU6216386A (en) 1987-03-12

Similar Documents

Publication Publication Date Title
AU2634592A (en) Improved interferon therapy
DE69003392T2 (en) DOSAGE FOR ORAL ADMINISTRATION OF HYPOGLYCAEMIC GLIPIZIDE.
ATE96308T1 (en) DOSAGE FORM FOR ADMINISTRATION IN HUMAN MEDICINE.
EG19642A (en) A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
KR100321467B1 (en)
DE3583849D1 (en) USE OF INTERFERON GAMMA (IFN-GAMMA) CONTAINERS FOR THE SYSTEMIC TREATMENT OF VARIOUS DISEASES OF HUMAN IN LOW DOSAGE.
GB8618466D0 (en) Administering medicaments to patients
ATE117548T1 (en) PHARMACEUTICAL PREPARATIONS FOR PREVENTING DRUG TOLERANCE.
HK25395A (en) Low dosage of interferon to enhance vaccine efficiency
SE9301290D0 (en) USE OF A SOMATOSTATIN ANALOGUE
EP0245433A4 (en) Major iron-regulated protein of neisseria gonorrhoeae and its use as vaccine.
EP0177342A3 (en) Oral formulation of therapeutic proteins
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
ZA874198B (en) D-fenfluramine for use in the treatment of depression
DE3686536D1 (en) OXYTOCIN AND ANTI-DAYS TO INTRODUCE BIRTH.
FR2600256B1 (en) DRUG AND DRUG COMPOSITION FOR THE TREATMENT OF TUMORS AND FOR THE TREATMENT OF VIRUS-INFECTIOUS DISEASES
EG17992A (en) Preparation of a medicament for arthritis and theumatism
EP0248583A3 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
Barrett Significance of oral bacteria in acute leukemia.
IT1284852B1 (en) Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases
IT1283945B1 (en) Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases
DK374388A (en) IMMUNTERAPEUTIC, ORAL INTERFERONDOSIS FORM AND PROCEDURE FOR PREPARING IT
MY102687A (en) Novel galenical comprising a somatostatin formulations.
HUP9902188A2 (en) Pharmaceutical compositions comprising natural human alfa-interferon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SCHERING AG, 13353 BERLIN, DE

8330 Complete renunciation